EFFICACY OF FLUTICASONE NASAL SPRAY Vs FLUTICASONE NASAL SPRAY AND TABLET FEXOFENADINE COMBINATION IN CASES OF ALLERGIC RHINITIS
Phase 4
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2023/09/057938
- Lead Sponsor
- KALINGA INSTITUTE OF MEDICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with age 18-59 years.
Patients who gave written informed consent.
Patients with TNSS >4.
Patients who come for regular follow up.
Exclusion Criteria
Upper or lower respiratory tract infection with in last 2 weeks of entry visit.
Patients with symptoms due to structural abnormalities such as grossly deviated nasal septum, nasal polyps, tumors.
Previous surgeries involving the nose and paranasal sinuses.
Use of systemic/oral corticosteroids within 30 days of the entry visit.
Hypersensitivity to antihistamines or corticosteroids.
Pregnant women. Unwilling to give consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TOTAL NASAL SYMPTOM SCORING LESS THAN 4Timepoint: MONTHLY FOR 2 MONTHS
- Secondary Outcome Measures
Name Time Method SYNERGISTIC ROLE OF FEXOFENADINE WITH STEROID NASAL SPRAY IN ALLERGIC RHINITISTimepoint: MONTHLY FOR 2 MONTHS